| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC | VP and Chief Compliance Office | Common Stock | 38.3K | $69.2K | $1.81 | Mar 23, 2024 | Direct |
| CUMBERLAND PHARMACEUTICALS INC | VP and Chief Compliance Office | Options (right to buy) | 16K | $27.4K | $1.71 | Mar 25, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 23, 2024 | 2 | $4.69K | 4 | Mar 26, 2024 | VP and Chief Compliance Office |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 24, 2023 | 1 | $0 | 4 | Mar 27, 2023 | VP and Chief Compliance Office |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 18, 2023 | 1 | -$2.46K | 4 | Mar 21, 2023 | VP and Chief Compliance Office |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 16, 2022 | 2 | -$3.51K | 4 | Apr 29, 2022 | VP and Chief Compliance Office |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | Mar 17, 2021 | 2 | -$8.24K | 4 | Jun 11, 2021 | VP and Chief Compliance Office |